Literature DB >> 11113875

Multiple tissue core arrays in histopathology research: a validation study.

C E Gillett1, R J Springall, D M Barnes, A M Hanby.   

Abstract

The use of multiple tissue arrays allows the examination of large cohorts of tumour tissue with economies of material and technical resources. It also permits the direct comparison of tissues on the same slide. In the present study, a series of 157 breast cancers was labelled with antibodies which recognize oestrogen (ER) and progesterone (PR) receptors and the staining obtained on whole tissue sections was compared with that from a series of multicore arrays. A highly significant association was found between the staining scores (0-7) obtained from the individual tissue sections and from the multicore arrays, although there was some discordance between the receptor status (positive/negative) of the whole section and the tissue core in 5% of cases for ER and in 6.5% of cases for PR. Multiple tissue cores represent an attractive way of dealing with large cohorts of tumours for research studies, because of the significant reduction in reagents and technical time required and the overall speed with which a study can be completed. A proportion of individual tissue cores were not representative of the diagnostic section, which limits the value of multicore arrays as a tool for patient management. However, the technique provides an efficient way of assessing the potential predictive value of novel proteins in different tumour types and in large cohorts. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113875     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH721>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

1.  A simple method for the construction of small format tissue arrays.

Authors:  A Hidalgo; P Piña; G Guerrero; M Lazos; M Salcedo
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Automated acquisition of stained tissue microarrays for high-throughput evaluation of molecular targets.

Authors:  Hans Vrolijk; Willem Sloos; Wilma Mesker; Patrick Franken; Riccardo Fodde; Hans Morreau; Hans Tanke
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

3.  Cell and tissue microarray technologies for protein and nucleic acid expression profiling.

Authors:  Marina Cardano; Giuseppe R Diaferia; Maurizio Falavigna; Chiara C Spinelli; Fausto Sessa; Pasquale DeBlasio; Ida Biunno
Journal:  J Histochem Cytochem       Date:  2012-11-19       Impact factor: 2.479

4.  Validation of tissue microarray technology in ovarian cancer: results from the Nurses' Health Study.

Authors:  Jonathan L Hecht; Joanne Kotsopoulos; Margaret A Gates; Susan E Hankinson; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

5.  Soy consumption and histopathologic markers in breast tissue using tissue microarrays.

Authors:  Gertraud Maskarinec; Eva Erber; Martijn Verheus; Brenda Y Hernandez; Jeffrey Killeen; Suzanne Cashin; J Mark Cline
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.

Authors:  David E Axelrod; Naomi Miller; Judith-Anne W Chapman
Journal:  Biomed Inform Insights       Date:  2009-01-01

7.  Tissue microarrays: one size does not fit all.

Authors:  Jeanette E Eckel-Passow; Christine M Lohse; Yuri Sheinin; Paul L Crispen; Christopher J Krco; Eugene D Kwon
Journal:  Diagn Pathol       Date:  2010-07-07       Impact factor: 2.644

8.  Prognosis for Survival of Young Women with Breast Cancer by Quantitative p53 Immunohistochemistry.

Authors:  David E Axelrod; Kinsuk Shah; Qifeng Yang; Bruce G Haffty
Journal:  Cancer Clin Oncol       Date:  2012

9.  Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.

Authors:  Anne A Blanchard; George P Skliris; Peter H Watson; Leigh C Murphy; Carla Penner; Ladislav Tomes; Tamara L Young; Etienne Leygue; Yvonne Myal
Journal:  Virchows Arch       Date:  2009-04-23       Impact factor: 4.064

10.  Securin promotes the identification of favourable outcome in invasive breast cancer.

Authors:  K Talvinen; H Karra; S Hurme; M Nykänen; A Nieminen; J Anttinen; T Kuopio; P Kronqvist
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.